| Ident. | Authors (with country if any) | Title |
|---|
| 001167 |
Harry R. Büller [Pays-Bas] ; Alex S. Gallus [Australie] ; Gerard Pillion [France] ; Martin H. Prins [Pays-Bas] ; Gary E. Raskob [États-Unis] | Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial |
| 004B42 |
Harry R. Büller [Pays-Bas, États-Unis, France, Australie, Canada, Italie] ; Bruce L. Davidson ; Hervé Decousus ; Alexander Gallus ; Michael Gent ; Franco Piovella ; Martin H. Prins ; Gary Raskob ; Annelise E. M. Segers ; Roger Cariou ; Oscar Leeuwenkamp ; Anthonie W. A. Lensing | Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis |
| 005676 |
Geno Merli [États-Unis, France, Norvège, Israël, Australie, Suède, Pologne] ; Theodore E. Spiro ; Carl-Gustav Olsson ; Ulrich Abildgaard ; Bruce L. Davidson ; Amiram Eldor ; Darlene Elias ; Andrew Grigg ; Dominique Musset ; George M. Rodgers ; Arthur A. Trowbridge ; Roger D. Yusen ; Krystyna Zawilska | Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease |
